Michael Alrutz - Feb 1, 2024 Form 4 Insider Report for CHIMERIX INC (CMRX)

Role
SVP AND GENERAL COUNSEL
Signature
/s/ Michael Alrutz, Attorney-in-Fact
Stock symbol
CMRX
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 06:30 PM
Previous filing
Jan 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CMRX Common Stock Award $0 +21.9K +14.96% $0.00 168K Feb 1, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRX Stock Option (Right to Buy) Award $0 +131K $0.00 131K Feb 1, 2024 Common Stock 131K $0.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares being reported are being issued pursuant to restricted unit awards ("RSUs"), each one of which represents a contingent right to receive one share of the Issuer's common stock. 5,468 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 5,468 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 5,471 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.
F2 Includes 1,809 shares acquired under the Issuer's Employee Stock Purchase Plan (the "ESPP") on March 10, 2023 and 2,399 shares acquired under the ESPP on September 8, 2023.
F3 1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.